Ronald J. Wooten serves as Executive at Revance Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Ronald J. Wooten has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 28, 2022 involved transacting 5 shares valued at $0.
Ronald J. Wooten currently holds 5 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald J. Wooten has been a net neutral trader of RVNC stock. They have purchased $0 and sold $0 worth of shares.
Ronald J. Wooten's most recent insider trade was on Sep 28, 2022, when they sold 5 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 11, 2014 | RVNC | $0 | Conversion | 658,551 | $N/A | Discretionary |
| Feb 11, 2014 | RVNC | $0 | Conversion | 2,039,382 | $N/A | Discretionary |